Genetic Ownership 2024 | Who Owns Genetic Now?

Institutional Ownership

0.00%

Institutional Holders

1.00

Genetic Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.00%	-	102,079	51,900	103.43%	118,412,000	Mar 31, 2023
OLD MISSION CAPITAL LLC	0.00%	0.00%	21,610	-48,631	-69.23%	25,067,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	15,864	15,864	100.00%	19,000	Mar 31, 2023
CETERA ADVISORS LLC	0.00%	0.00%	13,961	-	-	16,195,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	10,274	10,274	100.00%	11,918,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	7,900	7,900	100.00%	9,243,000	Mar 31, 2023
UBS GROUP AG	-	-	3,651	-3,744	-50.63%	4,235,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,208	1,208	100.00%	1,413,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,200	1,200	100.00%	1,404,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,000	-	-	1,160,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-76,881	-100.00%	-	Mar 31, 2023

Genetic's largest institutional shareholder is MORGAN STANLEY, holding 0.00% of the company's total share outstanding, currently valued at $118.41M. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.00%	0.00%	15,864	15,864	100.00%	19,000	Mar 31, 2023
OLD MISSION CAPITAL LLC	0.00%	0.00%	21,610	-48,631	-69.23%	25,067,000	Mar 31, 2023
CETERA ADVISORS LLC	0.00%	0.00%	13,961	-	-	16,195,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	10,274	10,274	100.00%	11,918,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	102,079	51,900	103.43%	118,412,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	7,900	7,900	100.00%	9,243,000	Mar 31, 2023
UBS GROUP AG	-	-	3,651	-3,744	-50.63%	4,235,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,000	-	-	1,160,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,208	1,208	100.00%	1,413,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,200	1,200	100.00%	1,404,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-76,881	-100.00%	-	Mar 31, 2023

The largest Genetic shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 15.86K shares of Genetic (GENE), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.00%	-	102,079	51,900	103.43%	118,412,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	15,864	15,864	100.00%	19,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	10,274	10,274	100.00%	11,918,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	7,900	7,900	100.00%	9,243,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,208	1,208	100.00%	1,413,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,200	1,200	100.00%	1,404,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,000	-	-	1,160,000	Mar 31, 2023
CETERA ADVISORS LLC	0.00%	0.00%	13,961	-	-	16,195,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	3,651	-3,744	-50.63%	4,235,000	Mar 31, 2023
OLD MISSION CAPITAL LLC	0.00%	0.00%	21,610	-48,631	-69.23%	25,067,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-76,881	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Genetic's largest institutional buyer is MORGAN STANLEY. The company purchased 51.90K stocks of GENE, valued at $118.41M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-76,881	-100.00%	-	Mar 31, 2023
OLD MISSION CAPITAL LLC	0.00%	0.00%	21,610	-48,631	-69.23%	25,067,000	Mar 31, 2023
UBS GROUP AG	-	-	3,651	-3,744	-50.63%	4,235,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
CETERA ADVISORS LLC	0.00%	0.00%	13,961	-	-	16,195,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,000	-	-	1,160,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,200	1,200	100.00%	1,404,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,208	1,208	100.00%	1,413,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	7,900	7,900	100.00%	9,243,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	10,274	10,274	100.00%	11,918,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.00%	0.00%	15,864	15,864	100.00%	19,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	102,079	51,900	103.43%	118,412,000	Mar 31, 2023

As of Mar 31 2023, Genetic's biggest institutional seller is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company sold -76.88K shares of GENE, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.00%	0.00%	15,864	15,864	100.00%	19,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	10,274	10,274	100.00%	11,918,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.00%	-	7,900	7,900	100.00%	9,243,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,208	1,208	100.00%	1,413,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	1,200	1,200	100.00%	1,404,000	Mar 31, 2023

Genetic's largest new institutional shareholder by number of shares is VIRTU FINANCIAL LLC, purchased 15.86K shares, valued at $19.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-76,881	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023

Genetic's largest sold out institutional shareholder by shares sold is SUSQUEHANNA INTERNATIONAL GROUP, LLP, sold -76.88K shares, valued at -, as of undefined.

Genetic Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
TRUST FOR PROFESSIONAL MANAGERS	0.00%	30,138	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	2,511	-	-	Feb 29, 2024

Genetic's largest mutual fund holder by % of total assets is "TRUST FOR PROFESSIONAL MANAGERS", owning 30.14K shares, compromising 0.00% of its total assets.

Genetic Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 19	1	-90.00%
30 Jun, 19	10	25.00%
31 Mar, 19	8	-
31 Dec, 18	8	-27.27%
30 Sep, 18	11	-
30 Jun, 18	11	-21.43%
31 Mar, 18	14	55.56%
31 Dec, 17	9	12.50%
30 Sep, 17	8	-38.46%
30 Jun, 17	13	30.00%
31 Mar, 17	10	-
31 Dec, 16	10	11.11%
30 Sep, 16	9	28.57%
30 Jun, 16	7	-12.50%
31 Mar, 16	8	-11.11%
31 Dec, 15	9	-
30 Sep, 15	9	12.50%
30 Jun, 15	8	-38.46%
31 Mar, 15	13	-

As of 30 Sep 19, 1 institutions are holding Genetic's shares, representing a decrease of -90.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 19	37	-99.99%
30 Jun, 19	594,442	-13.12%
31 Mar, 19	684,206	8.80%
31 Dec, 18	628,864	-7.63%
30 Sep, 18	680,793	-26.04%
30 Jun, 18	920,520	-23.71%
31 Mar, 18	1,206,613	14.84%
31 Dec, 17	1,050,683	-33.23%
30 Sep, 17	1,573,550	-14.11%
30 Jun, 17	1,832,053	-13.34%
31 Mar, 17	2,114,179	-22.97%
31 Dec, 16	2,744,659	429.58%
30 Sep, 16	518,271	19.77%
30 Jun, 16	432,707	18.29%
31 Mar, 16	365,793	-15.68%
31 Dec, 15	433,840	-27.17%
30 Sep, 15	595,686	-39.21%
30 Jun, 15	979,909	5.94%
31 Mar, 15	924,933	-

Genetic (GENE) has 37.00 shares outstanding as of 30 Sep 19, down -99.99% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 19	-	0.20%
30 Jun, 19	0.10%	622.31%
31 Mar, 19	0.13%	848.33%
31 Dec, 18	0.12%	693.99%
30 Sep, 18	0.13%	372.54%
30 Jun, 18	0.19%	307.99%
31 Mar, 18	0.25%	498.61%
31 Dec, 17	0.22%	200.03%
30 Sep, 17	0.33%	217.91%
30 Jun, 17	0.39%	191.85%
31 Mar, 17	0.45%	78.85%
31 Dec, 16	0.76%	3705.95%
30 Sep, 16	0.14%	896.20%
30 Jun, 16	0.13%	1108.62%
31 Mar, 16	0.11%	667.19%
31 Dec, 15	0.13%	419.29%
30 Sep, 15	0.17%	147.51%
30 Jun, 15	0.34%	327.08%
31 Mar, 15	0.32%	-

As of 30 Sep 19, Genetic is held by 0.00% institutional shareholders, representing a 0.20% growth compared to 30 Jun 19.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 19	1	-83.33%
30 Jun, 19	6	100.00%
31 Mar, 19	3	-
31 Dec, 18	3	-40.00%
30 Sep, 18	5	66.67%
30 Jun, 18	3	-57.14%
31 Mar, 18	7	133.33%
31 Dec, 17	3	-25.00%
30 Sep, 17	4	-50.00%
30 Jun, 17	8	60.00%
31 Mar, 17	5	-37.50%
31 Dec, 16	8	166.67%
30 Sep, 16	3	-40.00%
30 Jun, 16	5	25.00%
31 Mar, 16	4	-20.00%
31 Dec, 15	5	150.00%
30 Sep, 15	2	-66.67%
30 Jun, 15	6	-53.85%
31 Mar, 15	13	-

1 institutional shareholders have increased their position in GENE stock as of 30 Sep 19 compared to 6 in the previous quarter (a -83.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 19	-	-100.00%
30 Jun, 19	1	-50.00%
31 Mar, 19	2	-
31 Dec, 18	2	-
30 Sep, 18	2	-33.33%
30 Jun, 18	3	200.00%
31 Mar, 18	1	-66.67%
31 Dec, 17	3	200.00%
30 Sep, 17	1	-50.00%
30 Jun, 17	2	-
31 Mar, 17	2	100.00%
31 Dec, 16	1	-50.00%
30 Sep, 16	2	100.00%
30 Jun, 16	1	-50.00%
31 Mar, 16	2	-33.33%
31 Dec, 15	3	-50.00%
30 Sep, 15	6	200.00%
30 Jun, 15	2	-
31 Mar, 15	-	-

- institutional shareholders have reduced their position in GENE stock as of 30 Sep 19 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 19	1	-90.00%	37	-99.99%	-	0.20%	1	-83.33%	-	-100.00%
30 Jun, 19	10	25.00%	594,442	-13.12%	0.10%	622.31%	6	100.00%	1	-50.00%
31 Mar, 19	8	-	684,206	8.80%	0.13%	848.33%	3	-	2	-
31 Dec, 18	8	-27.27%	628,864	-7.63%	0.12%	693.99%	3	-40.00%	2	-
30 Sep, 18	11	-	680,793	-26.04%	0.13%	372.54%	5	66.67%	2	-33.33%
30 Jun, 18	11	-21.43%	920,520	-23.71%	0.19%	307.99%	3	-57.14%	3	200.00%
31 Mar, 18	14	55.56%	1,206,613	14.84%	0.25%	498.61%	7	133.33%	1	-66.67%
31 Dec, 17	9	12.50%	1,050,683	-33.23%	0.22%	200.03%	3	-25.00%	3	200.00%
30 Sep, 17	8	-38.46%	1,573,550	-14.11%	0.33%	217.91%	4	-50.00%	1	-50.00%
30 Jun, 17	13	30.00%	1,832,053	-13.34%	0.39%	191.85%	8	60.00%	2	-
31 Mar, 17	10	-	2,114,179	-22.97%	0.45%	78.85%	5	-37.50%	2	100.00%
31 Dec, 16	10	11.11%	2,744,659	429.58%	0.76%	3705.95%	8	166.67%	1	-50.00%
30 Sep, 16	9	28.57%	518,271	19.77%	0.14%	896.20%	3	-40.00%	2	100.00%
30 Jun, 16	7	-12.50%	432,707	18.29%	0.13%	1108.62%	5	25.00%	1	-50.00%
31 Mar, 16	8	-11.11%	365,793	-15.68%	0.11%	667.19%	4	-20.00%	2	-33.33%
31 Dec, 15	9	-	433,840	-27.17%	0.13%	419.29%	5	150.00%	3	-50.00%
30 Sep, 15	9	12.50%	595,686	-39.21%	0.17%	147.51%	2	-66.67%	6	200.00%
30 Jun, 15	8	-38.46%	979,909	5.94%	0.34%	327.08%	6	-53.85%	2	-
31 Mar, 15	13	-	924,933	-	0.32%	-	13	-	-	-

Genetic Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 26, 2004	PATOU GARY	officer	Chief Medical Officer	M-Exempt	Sell	2,500	$0.07	$175.00	1,138,020
Aug 26, 2004	PATOU GARY	officer	Chief Medical Officer	M-Exempt	Sell	5,500	$0.07	$385.00	1,132,520
Jul 06, 2004	HENNESSEY ROBERT J	director	-	M-Exempt	Sell	1,500	$1.63	$2.44K	597,367
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	10,947	$1.57	$17.19K	598,867
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	25,000	$5.22	$130.50K	587,920
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	547	$1.57	$858.79	562,920

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 26, 2004	PATOU GARY	officer	Chief Medical Officer	M-Exempt	Sell	2,500	$0.07	$175.00	1,138,020
Aug 26, 2004	PATOU GARY	officer	Chief Medical Officer	M-Exempt	Sell	5,500	$0.07	$385.00	1,132,520
Jul 06, 2004	HENNESSEY ROBERT J	director	-	M-Exempt	Sell	1,500	$1.63	$2.44K	597,367
Jul 01, 2004	KIRBY PAMELA J	director	-	A-Award	Buy	9,047	$1.49	$13.48K	34,047
Jul 01, 2004	KIRBY PAMELA J	director	-	A-Award	Buy	25,000	$4.97	$124.25K	25,000
Jul 01, 2004	KIRBY PAMELA J	director			Buy	-	-	-	-
May 10, 2004	STONE DAVID K	director	-	A-Award	Buy	184	$1.46	$268.64	127,665
May 10, 2004	RIEDEL NORBERT G	director	-	A-Award	Buy	184	$1.46	$268.64	137,896
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	10,947	$1.57	$17.19K	598,867
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	25,000	$5.22	$130.50K	587,920
Apr 16, 2004	HENNESSEY ROBERT J	director	-	A-Award	Sell	547	$1.57	$858.79	562,920
Apr 16, 2004	RIEDEL NORBERT G	director	-	A-Award	Buy	342	$1.57	$536.94	137,712
Apr 16, 2004	RIEDEL NORBERT G	director	-	A-Award	Buy	20,525	$1.57	$32.22K	137,370
Apr 16, 2004	RIEDEL NORBERT G	director	-	A-Award	Buy	25,000	$5.22	$130.50K	116,845
Apr 16, 2004	RIEDEL NORBERT G	director	-	A-Award	Buy	547	$1.57	$858.79	91,845
Apr 16, 2004	STONE DAVID K	director	-	A-Award	Buy	15,052	$1.57	$23.63K	127,481
Apr 16, 2004	STONE DAVID K	director	-	A-Award	Buy	25,000	$5.22	$130.50K	112,429
Apr 16, 2004	STONE DAVID K	director	-	A-Award	Buy	547	$1.57	$858.79	87,429
Apr 16, 2004	RUTTER WILLIAM J	director	-	A-Award	Buy	10,947	$1.57	$17.19K	59,218
Apr 16, 2004	RUTTER WILLIAM J	director	-	A-Award	Buy	10,833	$5.22	$56.55K	48,271

The last insider sell of Genetic's stock was made by PATOU GARY on Aug 26 2004, selling 2,500 shares at $0.07 per share (valued at $175.00).

Genetic Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Genetic Peer Ownership

Ticker	Company
HTGM	HTG Molecular Diagnostics, Inc.
BIOC	Biocept, Inc.
A	Agilent Technologies, Inc.
SQL	SeqLL Inc.
SERA	Sera Prognostics, Inc.
TTOO	T2 Biosystems, Inc.
BIAF	bioAffinity Technologies, Inc.
INBS	Intelligent Bio Solutions Inc.
PRPO	Precipio, Inc.
MDXH	MDxHealth SA

GENE Ownership FAQ

Who Owns Genetic?

Genetic is owned by institutional shareholders (0%), insiders (0.00%), and public (0%). The largest institutional shareholder of Genetic is MORGAN STANLEY (0.00% of total shares) and the top mutual fund owner is TRUST FOR PROFESSIONAL MANAGERS (0.00% of total shares).

Who are the major institutional shareholders of Genetic?

Genetic's major institutional shareholders are MORGAN STANLEY, OLD MISSION CAPITAL LLC, VIRTU FINANCIAL LLC, CETERA ADVISORS LLC, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 0.00% of the company's share outstanding.

How many Genetic shareholders are there?

As of Sep 2019, there are 1 institutional shareholders of Genetic.

What percentage of Genetic is owned by MORGAN STANLEY?

MORGAN STANLEY owns 102.08K shares of Genetic, representing 0.00% of the company's total shares outstanding, valued at $118.41M (as of Mar 2023).

What percentage of Genetic is owned by OLD MISSION CAPITAL LLC?

As of Mar 2023, OLD MISSION CAPITAL LLC holds 21.61K shares of Genetic (GENE), compromising 0.00% of the company, valued at $25.07M.

What percentage of Genetic is owned by VIRTU FINANCIAL LLC?

VIRTU FINANCIAL LLC is the third largest holder of Genetic. The company owns 15.86K of the company's shares outstanding (worth $19K).